Latest News & Updates

Breaking News

  • 47 minutes ago

  • Simantini Singh Deo

Ascentage Pharma Appoints Faiçal Miyara As Chief Business Officer And Jim Ziegler As Chief Commercial Officer
Breaking News
Novartis Wins FDA Approval For Pluvicto In Earlier Stage Metastatic Prostate Cancer, Expanding Patient Access

Simantini Singh Deo

Other trending news you may like to read

Ascentage Pharma Appoints Faiçal Miyara As Chief Business Officer And Jim Ziegler As Chief Commercial Officer

Ascentage Pharma names Dr. Faiçal Miyara as CBO and Jim Ziegler as CCO to drive its global business development and commercial expansion.

Simantini Singh Deo

Pharma Now

Novartis Wins FDA Approval For Pluvicto In Earlier Stage Metastatic Prostate Cancer, Expanding Patient Access

Novartis wins FDA approval for Pluvicto in earlier-stage metastatic hormone-sensitive prostate cancer, nearly doubling eligible patients.

Simantini Singh Deo

Pharma Now

XORTX Therapeutics Appoints Financial Services Veteran Depesh Narotam As Independent Director

XORTX Therapeutics appoints Depesh Narotam, a 20-year financial services veteran, as an independent director to its Board.

Simantini Singh Deo

Pharma Now

Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman As CEO To Lead Psilocybin Therapy Development

Rose Hill Life Sciences names Jama Pitman, a 25-year biopharma veteran, as CEO to lead its psilocybin-based clinical programs.

Simantini Singh Deo

Pharma Now